CD2AP and nonpapillary renal cell carcinoma: CD2AP expression was also associated with macrophage and neutrophil infiltration.<h4>Conclusions</h4>Taken together, our results suggest that CD2AP can be used as a diagnostic and prognostic biomarker in ccRCC patients and that DNA hypermethylation plays an important role in reducing CD2AP expression.